152 related articles for article (PubMed ID: 25777765)
1. Nitrogen permease regulator-like 2 enhances sensitivity to oxaliplatin in colon cancer cells.
Liu MN; Liu AY; Du YJ; Pei FH; Wang XH; Chen J; Liu D; Liu BR
Mol Med Rep; 2015 Jul; 12(1):1189-96. PubMed ID: 25777765
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Nitrogen Permease Regulator Like-2 (NPRL2) Enhances Sensitivity to Irinotecan (CPT-11) in Colon Cancer Cells by Activating the DNA Damage Checkpoint Pathway.
Liu S; Liu B
Med Sci Monit; 2018 Mar; 24():1424-1433. PubMed ID: 29519997
[TBL] [Abstract][Full Text] [Related]
3. GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway.
Yu T; An Q; Cao XL; Yang H; Cui J; Li ZJ; Xiao G
Life Sci; 2020 Nov; 260():118294. PubMed ID: 32818544
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy.
Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
Oncol Rep; 2016 Dec; 36(6):3682-3690. PubMed ID: 27779719
[TBL] [Abstract][Full Text] [Related]
5. Nitrogen Permease Regulator-Like-2 Exhibited Anti-Tumor Effects And Enhanced The Sensitivity Of Colorectal Cancer Cells To Oxaliplatin And 5-Fluorouracil.
Liu A; Qiao J; He L; Liu Z; Chen J; Pei F; Du Y
Onco Targets Ther; 2019; 12():8637-8644. PubMed ID: 31695423
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of nitrogen permease regulator like-2 activates PDK1-AKT1 and contributes to the malignant growth of glioma cells.
Huang N; Cheng S; Mi X; Tian Q; Huang Q; Wang F; Xu Z; Xie Z; Chen J; Cheng Y
Mol Carcinog; 2016 Nov; 55(11):1613-1626. PubMed ID: 26455908
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
Zhang HR; Chen JM; Zeng ZY; Que WZ
J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
[TBL] [Abstract][Full Text] [Related]
8. NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway.
Luo S; Shao L; Chen Z; Hu D; Jiang L; Tang W
Exp Cell Res; 2020 May; 390(2):111981. PubMed ID: 32234375
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of the nitrogen permease regulator-like-2 candidate tumor suppressor gene in colorectal cancer cell lines.
Liu AY; Liu MN; Pei FH; Chen J; Wang XH; Liu D; Du YJ; Liu BR
Mol Med Rep; 2015 Sep; 12(3):3487-3493. PubMed ID: 26044952
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells.
Kawahara S; Otsuji Y; Nakamura M; Murakami M; Murate T; Matsunaga T; Kanoh H; Seishima M; Banno Y; Hara A
Anticancer Drugs; 2013 Jun; 24(5):473-83. PubMed ID: 23426175
[TBL] [Abstract][Full Text] [Related]
11. [MiR-145 inhibits drug resistance to Oxaliplatin in colorectal cancer cells through regulating G protein coupled receptor 98].
Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):566-570. PubMed ID: 28534337
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
[TBL] [Abstract][Full Text] [Related]
13. Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP.
Tang H; Liu YJ; Liu M; Li X
Anticancer Drugs; 2007 Jul; 18(6):633-9. PubMed ID: 17762391
[TBL] [Abstract][Full Text] [Related]
14. Functional mechanism of the enhancement of 5-fluorouracil sensitivity by TUSC4 in colon cancer cells.
Liu MN; Liu AY; Pei FH; Ma X; Fan YJ; DU YJ; Liu BR
Oncol Lett; 2015 Dec; 10(6):3682-3688. PubMed ID: 26788191
[TBL] [Abstract][Full Text] [Related]
15. Targeting NPRL2 to enhance the efficacy of Olaparib in castration-resistant prostate cancer.
Chen X; Chen Z; Zheng B; Tang W
Biochem Biophys Res Commun; 2019 Jan; 508(2):620-625. PubMed ID: 30522863
[TBL] [Abstract][Full Text] [Related]
16. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells.
Tanaka S; Hosokawa M; Yonezawa T; Hayashi W; Ueda K; Iwakawa S
Biol Pharm Bull; 2015; 38(3):435-40. PubMed ID: 25757925
[TBL] [Abstract][Full Text] [Related]
17. NPRL2 reduces the niraparib sensitivity of castration-resistant prostate cancer via interacting with UBE2M and enhancing neddylation.
Zhao X; Jiang L; Hu D; Tang Y; Zhao G; Du X; Luo S; Tang W
Exp Cell Res; 2021 Jun; 403(2):112614. PubMed ID: 33905671
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation.
Nemoto S; Nakamura M; Osawa Y; Kono S; Itoh Y; Okano Y; Murate T; Hara A; Ueda H; Nozawa Y; Banno Y
J Biol Chem; 2009 Apr; 284(16):10422-32. PubMed ID: 19240026
[TBL] [Abstract][Full Text] [Related]
19. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
Wu YZ; Lin HY; Zhang Y; Chen WF
J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
[TBL] [Abstract][Full Text] [Related]
20. PEG-liposomal oxaliplatin induces apoptosis in human colorectal cancer cells via Fas/FasL and caspase-8.
Yang C; Liu HZ; Fu ZX
Cell Biol Int; 2012 Mar; 36(3):289-96. PubMed ID: 21888623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
